Michael Palmedo named Shamnad Basheer IP/Trade Fellow

Less than three months ago, Professor Shamnad Basheer from India had his singular career in IP and social justice cut short at the age of 43 (here and here). One of Shamnad's principal interests was the pharmaceutical industry and how IP, trade and regulatory law impact on the availability of drugs.

Shortly after his death, the Association for Accessible Medicines, in collaboration with the Texas A&M University School of Law, established the Shamnad Basheer IP/Trade Fellowship and invited interested scholars to submit applications.

The selected fellow will work with Professor Srividhya Ragavan of the Texas A&M University School of Law and Jonathan Kimball of the Association for Accessible Medicines to produce a white paper that examines the Special 301 submissions of the Pharmaceutical Research and Manufacturers of America to the Office of the U.S. Trade Representative.

The recipient of the fellowship has been announced, Michael Palmedo. Mr. Palmedo is Assistant Director for Interdisciplinary Research at American University, Washington College of Law’s Program on Information Justice and Intellectual Property.

Mr. Palmedo's scholarly interests lie at the intersection of intellectual property law, international trade and economics. In this connection, he has presented on a variety of intellectual property topics to trade negotiators at Free Trade Agreement negotiating rounds and well as publish in a number of IP areas.

IPKat congratulates Mr. Palmedo in being selected and hopes that he will be able to contribute to IPKat at the conclusion of his fellowship to share his findings and conclusions with IPKat readers.

By Neil Wilkof
Michael Palmedo named Shamnad Basheer IP/Trade Fellow Michael Palmedo named Shamnad Basheer IP/Trade Fellow Reviewed by Neil Wilkof on Sunday, November 03, 2019 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Powered by Blogger.